In May 2023, the Company entered into the Supply and Manufacturing Agreement (the “HA+ Supply Agreement”) with the Distributor whereby the Distributor is the exclusive contract manufacturer of the Ax…
The Company entered into a Term Loan Agreement, dated June 30, 2020 (as amended from time to time, the “Credit Facility”), with Oberland Capital and its affiliates, TPC Investments II LP and Argo LLC…
The Company entered into a Term Loan Agreement, dated June 30, 2020 (as amended from time to time, the “Credit Facility”), with Oberland Capital and its affiliates, TPC Investments II LP and Argo LLC…
The Company entered into a Term Loan Agreement, dated June 30, 2020 (as amended from time to time, the “Credit Facility”), with Oberland Capital and its affiliates, TPC Investments II LP and Argo LLC…
The Company pays a third party a facility fee for the use of cleanrooms, manufacturing, storage, and office space and for services in support of its tissue processing
Axogen, Inc. Customers
No clients on recordNo downstream customers found in our database for Axogen, Inc..
Axogen, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
AXGN-DEBT
Debt stack $20.6M
90%
Market cache reports total debt of $20.6M.
Axogen, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Axogen, Inc..
Axogen, Inc. Ownership
Holder
Name
Confidence
Evidence
AXGN-OWNER-MORGAN-STANLEY
MORGAN STANLEY
90%
13F overlay lists MORGAN STANLEY as top holder; 222 tracked holders.
Axogen, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
